Ligand validation:6FJE

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6FJE_EDO_A_1008	22%	83%	0.241	0.856	0.44	0.35	-	-	2	0	100%	1
6FJE_EDO_A_1005	20%	66%	0.203	0.806	0.84	0.48	-	-	1	0	100%	1
6FJE_EDO_B_1005	11%	76%	0.215	0.727	0.64	0.32	-	-	0	0	100%	1
6FJE_EDO_B_1006	7%	65%	0.365	0.819	0.79	0.57	-	-	1	0	100%	1
6FJE_EDO_B_1007	4%	86%	0.567	0.949	0.34	0.37	-	-	2	0	100%	1
6FJE_EDO_A_1004	3%	55%	0.388	0.745	0.92	0.83	-	-	1	0	100%	1
6FJE_EDO_A_1007	3%	77%	0.564	0.91	0.53	0.39	-	-	2	0	100%	1
6FJE_EDO_A_1006	2%	62%	0.463	0.768	0.81	0.65	-	-	0	0	100%	1
6FJE_EDO_B_1008	2%	79%	0.461	0.758	0.7	0.17	-	-	0	0	100%	1
6FJE_EDO_B_1009	2%	62%	0.445	0.716	0.85	0.63	-	-	0	0	100%	1
6FJE_EDO_B_1010	2%	75%	0.605	0.872	0.57	0.41	-	-	0	0	100%	1
5NSL_EDO_B_2031	48%	84%	0.11	0.851	0.54	0.23	-	-	0	0	100%	1
5O47_EDO_A_2006	43%	82%	0.144	0.867	0.52	0.28	-	-	0	0	100%	1
6FJG_EDO_B_1004	30%	84%	0.153	0.816	0.54	0.24	-	-	0	0	100%	1
6ANS_EDO_A_404	100%	89%	0.029	0.995	0.57	0.07	-	-	0	0	100%	1
4ITB_EDO_A_503	100%	88%	0.028	0.99	0.38	0.29	-	-	0	0	100%	1
4FQI_EDO_A_401	100%	85%	0.032	0.992	0.46	0.29	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.